Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
03/1999
03/31/1999CN1212622A Use of antagnoist of PPAR-alpha and PPAR-gamma for treatment of syndrom X
03/31/1999CN1212620A Mercapto derivatives as inhibitors of cyclooxygenases
03/31/1999CN1042730C Method for preparing pyrazolopyridine compound
03/30/1999US5889145 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
03/30/1999US5889049 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
03/30/1999US5889042 Method of treating diseases and conditions with estrogen agonists and antagonists
03/30/1999US5889036 Prophylactic or therapeutic drug for renal diseases
03/30/1999US5889002 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
03/30/1999US5888986 Method for treating the urinary bladder and associated structures using hyaluronic acid
03/30/1999US5888964 Method for increasing placental blood flow
03/30/1999US5888812 Myeloid cell leukemia associated gene MCL-1
03/30/1999US5888771 Gene products as targets for the development of antibiotics.
03/30/1999US5888770 Spoiiie
03/30/1999CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014213A1 Substituted chroman derivatives
03/25/1999WO1999014212A1 Substituted chroman derivatives
03/25/1999WO1999013885A1 Modulation of immune responses
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2304982A1 Sense mrna therapy
03/25/1999CA2304119A1 Modulation of immune responses
03/25/1999CA2304037A1 Substituted chroman derivatives
03/25/1999CA2303926A1 Substituted chroman derivatives
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303227A1 Human prl-1 phosphatase
03/25/1999CA2244971A1 Mure
03/24/1999EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/24/1999EP0902779A2 Phosphate mimics
03/24/1999EP0480950B1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
03/23/1999US5886039 Administering to uretha a lipophilic active agent selected from the group consisting of vasoactive prostaglandins
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999CA2130878C 4-aminopyrimidine derivatives
03/23/1999CA2008771C Pyridinium nitrate, its production and use
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999012916A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999WO1999012905A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999WO1999012541A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
03/18/1999CA2569685A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999CA2296358A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/17/1999EP0902022A1 Novel benzofuranone derivatives and process for producing the same
03/17/1999EP0902018A2 2-(Arylphenyl)amino-imidazoline derivatives
03/17/1999EP0901470A1 Indole derivatives useful as endothelin receptor antagonists
03/17/1999EP0831858A4 Intrauterine chemical necrosing method and composition
03/17/1999EP0655058B1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
03/17/1999EP0616536B1 Use of decorin or biglycan for the manufacture of a medicament in the treatment of diabetes-associated pathology
03/17/1999EP0565634B1 Angiotensin ii receptor blocking compositions
03/17/1999CN1211238A Benzimidazole derivatives
03/17/1999CN1211189A Urogenital and intestinal disorder compositions comprising a substrance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
03/17/1999CN1211188A Urogenital and intestinal compositions
03/16/1999US5883133 Cardiovascular disorders
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5883090 Endothelin receptor antagonists
03/16/1999US5883075 Hypotensive agent cyclic peptides
03/16/1999US5882656 Useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and
03/16/1999CA2244232A1 Novel def
03/16/1999CA2165012C Estrogen agonists
03/16/1999CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999WO1999011286A1 Vaginal suppository vaccine for urogenital infections
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011258A1 Lymphocyte function antigen-1 antagonists
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999CA2302505A1 Vaginal suppository vaccine for urogenital infections
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302364A1 Il-8 receptor antagonists
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900844A2 Membrane protein of Staphylococcus aureus
03/10/1999EP0900081A1 Inhibitors of farnesyl-protein transferase
03/10/1999EP0900080A1 Novel indole and benzothiazole derivatives
03/10/1999EP0494158B1 A recombinant birth control vaccine
03/10/1999CN1210001A Application of tea pigments in preparation of medicine for nephrotic syndrome
03/09/1999US5880267 Trophinin and trophinin-assisting protein agonists, antibodies and antagonists
03/09/1999US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction
03/09/1999US5880093 Useful in prevention of spontaneous abortion and premature labor
03/09/1999US5879908 CRFG-1a, a target and marker for chronic renal failure
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/04/1999WO1999010339A1 2-aminopyridines containing fused ring substituents as nos inhibitors
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999009985A1 Inhibitors of prenyl-protein transferase
03/04/1999WO1999009970A1 Urinary incontinence therapy
03/04/1999WO1998055606A3 Lactoferrin receptor genes of moraxella
03/04/1999CA2301770A1 Inhibitors of prenyl-protein transferase
03/04/1999CA2245755A1 2-(arylphenyl)amino-imidazoline derivatives
03/04/1999CA2242260A1 Spo0j1
03/04/1999CA2242258A1 Novel compounds
03/03/1999EP0899336A2 Streptococcus pneumoniae spoIIIE protein
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 562